-
141
Sensitivity Study of Four Land Surface Schemes in the WRF Model
Published 2010-01-01Get full text
Article -
142
-
143
Associations between local COVID-19 policies and anxiety in the USA: a longitudinal digital cohort study
Published 2025-01-01Get full text
Article -
144
-
145
-
146
-
147
-
148
The Influence of Prior Obstetrical History on Current 17-Hydroxyprogesterone Caproate Use
Published 2011-01-01Get full text
Article -
149
-
150
-
151
Update on Surgical Techniques Best Practices to Optimize Outcomes Following Gel Stent Implantation
Published 2025-01-01“…Vanessa Vera,1 Arsham Sheybani,2 Joseph F Panarelli,3 Davinder S Grover,4 James Lee,5 Earl Randy Craven,2 Thomas W Samuelson,6 Iqbal Ike K Ahmed7 1Allergan, an AbbVie company, Irvine, CA, USA; 2Washington University School of Medicine, St Louis, MO, USA; 3Department of Ophthalmology, New York University Langone Health, New York, NY, USA; 4Glaucoma Associates of Texas, Dallas, TX, USA; 5Colorado Eye Institute, Colorado Springs, CO, USA; 6Minnesota Eye Consultants, University of Minnesota, Minneapolis, MN, USA; 7John Moran Eye Center, University of Utah, Salt Lake City, UT, USACorrespondence: James Lee, Colorado Eye Institute, Colorado Springs, CO, 80924, USA, Email jlee@eyescolorado.comAbstract: The XEN® 45 Glaucoma Treatment System (gel stent; Allergan, an AbbVie company, Irvine, CA, USA) is a minimally invasive bleb-forming surgical device that was originally approved to lower intraocular pressure by diverting the aqueous humor from the anterior chamber to the subconjunctival space (like trabeculectomy) following ab-interno placement. …”
Get full text
Article -
152
Photofate of Tetrabromobisphenol-A in the Arctic: Role of photofluence and dissolved organic matter
Published 2024-12-01Get full text
Article -
153
New Insights into the PPARγ Agonists for the Treatment of Diabetic Nephropathy
Published 2014-01-01Get full text
Article -
154
-
155
-
156
Plantar sensation associates with gait instability in older adults
Published 2025-01-01Get full text
Article -
157
-
158
-
159
The Diagnostic Journey of Dysautonomia Patients: Insights from a Patient-Reported Outcome Study
Published 2025-01-01Get full text
Article -
160
Impact of mask wearing time on fluid consumption and physical activity during the COVID-19 pandemic
Published 2025-01-01Get full text
Article